Skip to content
★ Sign in to follow
JW

Johan Waldhe

Prostatype Genomics AB
Total declarations
3
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 18 Sept 2024 for Prostatype Genomics AB, €54k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

Johan Waldhe: trading record in brief

All filings by Johan Waldhe on record concern Prostatype Genomics AB. Between 4 September 2024 and 12 September 2024, the trades on record add up to 3 filings.

The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The latest filing, published on 18 September 2024, reports a transaction of €54k in Prostatype Genomics AB. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 6 days. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Johan Waldhe

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ●
    StyrelseledamotExecutivesProstatype Genomics AB
    612,189 SEK0FI-SE
    12,243,780 shares@ SEK 0.0512.9% of flowBTU (betald tecknad unit)ISIN SE0022574570FI:csv-e6f5350fafc6e39233a9
  • ●
    StyrelseledamotExecutivesProstatype Genomics AB
    150,008 SEK0FI-SE
    3,000,150 shares@ SEK 0.053.1% of flowBTU (betald tecknad unit)ISIN SE0022574570FI:csv-bb74ebf0896c5bcbd200
  • ●
    StyrelseledamotExecutivesProstatype Genomics AB
    4M SEK0FI-SE
    79,749,649 shares@ SEK 0.0584.0% of flowBTU (betald tecknad unit)ISIN SE0022574570FI:csv-109af61dd477cc6abbdd

3 of 3 declarations